Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 13Weight Loss 5Obesity 5Overweight 2Menstruation Disturbances 2Intermittent Fasting 2Insulin Resistance 2Tumor Surgery 1Sarcopenia 1Postoperative Complications 1Obesity, Abdominal 1Muscle Weakness 1Motor Activity 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Glucocorticoid Receptor Deficiency 1Fasting 1Esophageal Neoplasms 1Colorectal Neoplasms 1Breast Cancer Female 1Body Weight 1

Interventions

Exercise 236Resistance Training 32Surveys and Questionnaires 22High-Intensity Interval Training 20Walking 15Preoperative Exercise 13Methods 13Diet 13Exercise Therapy 12Control Groups 11Standard of Care 10Nutritional Status 9Counseling 8Nutrition Assessment 7methyl hydroxyethyl cellulose 5Fitness Trackers 5Diet Therapy 5Physical Therapy Modalities 4Nutritional Support 4Motivational Interviewing 4Interviews as Topic 4Educational Status 4Cognitive Behavioral Therapy 4Behavior Therapy 4Therapeutics 3Rehabilitation 3Palliative Care 3Metformin 3Exercise Test 3Diet, Mediterranean 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Motor Activity × Caloric Restriction × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡